Dr Behzad Hajarizadeh

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, 'Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.', J Hepatol, http://dx.doi.org/10.1016/j.jhep.2017.07.025

Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T, 2017, 'Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2017.05.020

Cunningham EB; Hajarizadeh B; Dalgard O; Amin J; Hellard M; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G, 2017, 'Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', BMC Infectious Diseases, vol. 17, http://dx.doi.org/10.1186/s12879-017-2517-3

Midgard H; Hajarizadeh B; Cunningham EB; Conway B; Backmund M; Bruggmann P; Bruneau J; Bourgeois S; Dunlop A; Foster GR, 2017, 'Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2017.05.040

Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV, 2017, 'HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs', Current HIV/AIDS Reports, vol. 14, pp. 110 - 121, http://dx.doi.org/10.1007/s11904-017-0358-8

Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M, 2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, vol. 2, pp. 514 - 520, http://dx.doi.org/10.1016/S2468-1253(17)30075-4

Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M, 2017, 'Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse', Journal of Clinical Virology, vol. 92, pp. 32 - 38, http://dx.doi.org/10.1016/j.jcv.2017.05.007

Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, vol. 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701

Hajarizadeh B, 2017, 'Generic direct acting antiviral treatment: The first step towards elimination of hepatitis C in Iran', Hepatitis Monthly, vol. 17, pp. 1 - 3, http://dx.doi.org/10.5812/hepatmon.45788

Blach S; Zeuzem S; Manns M; Altraif I; Duberg AS; Muljono DH; Waked I; Alavian SM; Lee MH; Negro F, 2017, 'Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study', The Lancet Gastroenterology and Hepatology, vol. 2, pp. 161 - 176, http://dx.doi.org/10.1016/S2468-1253(16)30181-9

Hajarizadeh B; Grebely J; McManus H; Estes C; Razavi H; Gray RT; Alavi M; Amin J; McGregor S; Sievert W, 2017, 'Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 32, pp. 229 - 236, http://dx.doi.org/10.1111/jgh.13453

Esmaeili A; Mirzazadeh A; Carter GM; Esmaeili A; Hajarizadeh B; Sacks HS; Page KA, 2017, 'Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis', Journal of Viral Hepatitis, vol. 24, pp. 117 - 127, http://dx.doi.org/10.1111/jvh.12628

Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ, 2016, 'Hepatitis C treatment as prevention: evidence, feasibility, and challenges', The Lancet Gastroenterology and Hepatology, vol. 1, pp. 317 - 327, http://dx.doi.org/10.1016/S2468-1253(16)30075-9

Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ, 2016, 'Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study', Journal of Hepatology, vol. 65, pp. 879 - 887, http://dx.doi.org/10.1016/j.jhep.2016.06.025

Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ, 2016, 'Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014)', Journal of Hepatology, vol. 65, pp. 1086 - 1093, http://dx.doi.org/10.1016/j.jhep.2016.08.010

Alavian SM; Hajarizadeh B; Lankarani KB; Sharafi H; Daryani NE; Merat S; Mohraz M; Mardani M; Fattahi MR; Poustchi H, 2016, 'Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline', Hepatitis Monthly, vol. 16, http://dx.doi.org/10.5812/hepatmon.guideline

Hajarizadeh B; Richmond J; Ngo N; Lucke J; Wallace J, 2016, 'Hepatitis B-related concerns and anxieties among people with chronic hepatitis B in Australia', Hepatitis Monthly, vol. 16, http://dx.doi.org/10.5812/hepatmon.35566

Hajarizadeh B; Razavi-Shearer D; Merat S; Alavian SM; Malekzadeh R; Razavi H, 2016, 'Liver disease burden of hepatitis C virus infection in Iran and the potential impact of various treatment strategies on the disease burden', Hepatitis Monthly, vol. 16, http://dx.doi.org/10.5812/hepatmon.37234

Sheridan DA; Hajarizadeh B; Fenwick FI; Matthews GV; Applegate T; Douglas M; Neely D; Askew B; Dore GJ; Lloyd AR, 2016, 'Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection', Liver International, vol. 36, pp. 1774 - 1782, http://dx.doi.org/10.1111/liv.13176

Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, vol. 13, http://dx.doi.org/10.1186/s12985-016-0482-x

Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Richmond J; Hajarizadeh B; Wallace J, 2015, 'Patients' perspectives on the delivery of hepatitis B management and care', Australian family physician, vol. 44, pp. 346

Hajarizadeh B; Wallace J; Richmond J; Ngo N; Enright C, 2015, 'Hepatitis B knowledge and associated factors among people with chronic hepatitis B', Australian and New Zealand Journal of Public Health, vol. 39, pp. 563 - 568, http://dx.doi.org/10.1111/1753-6405.12378

Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003

Sibley A; Han KH; Abourached A; Lesmana LA; Makara M; Jafri W; Salupere R; Assiri AM; Goldis A; Abaalkhail F, 2015, 'The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - Volume 3', Journal of Viral Hepatitis, vol. 22, pp. 21 - 41, http://dx.doi.org/10.1111/jvh.12476

Sacks-Davis R; Grebely J; Dore GJ; Osburn W; Cox AL; Rice TM; Spelman T; Bruneau J; Prins M; Kim AY, 2015, 'Hepatitis c virus reinfection and spontaneous clearance of reinfection - The InC³ study', Journal of Infectious Diseases, vol. 212, pp. 1407 - 1419, http://dx.doi.org/10.1093/infdis/jiv220

Alfaleh FZ; Nugrahini N; Matičič M; Tolmane I; Alzaabi M; Hajarizadeh B; Valantinas J; Kim DY; Hunyady B; Abaalkhail F, 2015, 'Strategies to manage hepatitis C virus infection disease burden - Volume 3', Journal of Viral Hepatitis, vol. 22, pp. 42 - 65, http://dx.doi.org/10.1111/jvh.12474

Liakina V; Hamid S; Tanaka J; Olafsson S; Sharara AI; Alavian SM; Gheorghe L; El Hassan ES; Abaalkhail F; Abbas Z, 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3', Journal of Viral Hepatitis, vol. 22, pp. 4 - 20, http://dx.doi.org/10.1111/jvh.12475

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M, 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC³ study', Journal of Viral Hepatitis, vol. 22, pp. 708 - 717, http://dx.doi.org/10.1111/jvh.12384

Hajarizadeh B; Wallace J; Richmond J; Ngo N; Enright C, 2015, 'Hepatitis B knowledge and associated factors among people with chronic hepatitis B', Australian and New Zealand Journal of Public Health, http://dx.doi.org/10.1111/1753-6405.12378

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M, 2015, 'Patterns of hepatitis C Virus RNA levels during acute infection: The InC³ study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0122232

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC³ Study', Journal of Clinical Virology, vol. 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027

Keshvari M; Sharafi H; Hajarizadeh B; Alavian SM, 2014, 'Can we include genetic variants with high linkage disequilibrium into a multiple logistic model?', Liver International, vol. 34, pp. 964 - 964, http://dx.doi.org/10.1111/liv.12464

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J, 2014, 'Dynamics of HCV RNA levels during acute hepatitis C virus infection', Journal of Medical Virology, http://dx.doi.org/10.1002/jmv.24010

Grebely J; Grady B; Hajarizadeh B; Page K; Dore GJ, 2014, 'Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?', Hepatology, vol. 59, pp. 1650 - 1651, http://dx.doi.org/10.1002/hep.26675

Keshvari M; Pouryasin A; Behnava B; Sharafi H; Hajarizadeh B; Alavian SM, 2014, 'Letter: The rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C', Alimentary Pharmacology and Therapeutics, vol. 39, pp. 343, http://dx.doi.org/10.1111/apt.12589

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL, 2013, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, http://dx.doi.org/10.1002/hep.26639

Wallace J; Hajarizadeh B; Richmond J; McNally S, 2013, 'Challenges in managing patients in Australia with chronic hepatitis B: The General Practitioners' perspective', Australian and New Zealand Journal of Public Health, vol. 37, pp. 405 - 410, http://dx.doi.org/10.1111/1753-6405.12127

Hajarizadeh B; Grebely J; Dore GJ, 2013, 'Epidemiology and natural history of HCV infection', Nature Reviews Gastroenterology and Hepatology, http://dx.doi.org/10.1038/nrgastro.2013.107

Wallace J; McNally S; Richmond J; Hajarizadeh B; Pitts M, 2012, 'Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia', Sexual Health, vol. 9, pp. 131 - 137, http://dx.doi.org/10.1071/SH10137

Wallace J; Hajarizadeh B; Richmond J; McNally S; Pitts M, 2012, 'Managing chronic hepatitis B The role of the GP', Australian Family Physician, vol. 41, pp. 893 - 898

Hajarizadeh B; Grebely J; Dore GJ, 2012, 'Case definitions for acute hepatitis C virus infection: A systematic review', Journal of Hepatology, vol. 57, pp. 1349 - 1360, http://dx.doi.org/10.1016/j.jhep.2012.07.007

Wallace J; McNally S; Richmond J; Hajarizadeh B; Pitts M, 2011, 'Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia', BMC Research Notes, vol. 4, http://dx.doi.org/10.1186/1756-0500-4-45

Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B, 2009, 'Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures', Liver International, vol. 29, pp. 159 - 163, http://dx.doi.org/10.1111/j.1478-3231.2008.01790.x

Tavallaii SA; Mirzamani M; Heshmatzade Behzadi A; Assari S; Khoddami Vishteh HR; Hajarizadeh B; Einollahi B, 2009, 'Sexual function: A comparison between male renal transplant recipients and hemodialysis patients', Journal of Sexual Medicine, vol. 6, pp. 142 - 148, http://dx.doi.org/10.1111/j.1743-6109.2008.01047.x

Movahedi M; Hajarizadeh B; Rahimi A; Arshinchi M; Amirhosseini K; Haghdoost AA, 2009, 'Trends and geographical inequalities of the main health indicators for rural Iran', Health Policy and Planning, vol. 24, pp. 229 - 237, http://dx.doi.org/10.1093/heapol/czp007

Alavian SM; Gooya MM; Hajarizadeh B; Esteghamati AR; Moeinzadeh AM; Haghazali M; Zamani GA; Yaghini F; Lankarani KB, 2009, 'Mass vaccination campaign against hepatitis B in adolescents in Iran: Estimating coverage using administrative data', Hepatitis Monthly, vol. 9, pp. 189 - 195

Shariat-Torbaghan S; Emami-Aleagha M; Sedighi S; Azadbakht F; Keshvari A; Hajarizadeh B; Rosai J, 2009, 'Squamous cell carcinoma arising in an ovarian mature cystic teratoma: A case report', Archives of Iranian Medicine, vol. 12, pp. 186 - 189

Sali S; Alavian SM; Hajarizadeh B, 2008, 'Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients', Nephrology, vol. 13, pp. 376 - 379, http://dx.doi.org/10.1111/j.1440-1797.2008.00952.x

Movahedi M; Haghdoost AA; Pournik O; Hajarizadeh B; Fallah MS, 2008, 'Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades', Journal of Public Health, vol. 30, pp. 499 - 504, http://dx.doi.org/10.1093/pubmed/fdn071

Alavian SM; Hajarizadeh B; Ahmadzad-Asl M; Kabir A; Bagheri-Lankarani K, 2008, 'Hepatitis B virus infection in Iran: A systematic review', Hepatitis Monthly, vol. 8, pp. 281 - 294

Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MMA; Faridi AR, 2006, 'Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study', Archives of Iranian Medicine, vol. 9, pp. 319 - 323

Jahani MR; Alavian SM; Shirzad H; Kabir A; Hajarizadeh B, 2005, 'Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour" [9]', Sexually Transmitted Infections, vol. 81, pp. 185, http://dx.doi.org/10.1136/sti.2004.011114

Alavian SM; Hajarizadeh B, 2004, 'Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs [7]', Gut, vol. 53, pp. 1057

Alavian SM; Hajarizadeh B; Nematizadeh F; Larijini B, 2004, 'Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease', BMC Endocrine Disorders, vol. 4, http://dx.doi.org/10.1186/1472-6823-4-4

Einollahi B; Hajarizadeh B; Bakhtiari S; Lesanpezeshki M; Khatami MR; Nourbala MH; Pourfarziani V; Alavian SM, 2003, 'Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients', Journal of Gastroenterology and Hepatology (Australia), vol. 18, pp. 836 - 840, http://dx.doi.org/10.1046/j.1440-1746.2003.03063.x

Alavian SM; Einollahi B; Hajarizadeh B; Bakhtiari S; Nafar M; Ahrabi S, 2003, 'Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients', Nephrology, vol. 8, pp. 256 - 260, http://dx.doi.org/10.1046/j.1440-1797.2003.00166.x

Einollahi B; Hajarizadeh B; Simforoosh N; Lessanpezeshki M; Khatami MR; Nourbala MH; Basiri A; Pourfarziani V; Firoozan A; Nafar M, 2003, 'Patient and graft outcome after living donor renal transplantation in Iran: More than 15-year follow-up', Transplantation Proceedings, vol. 35, pp. 2605 - 2606, http://dx.doi.org/10.1016/j.transproceed.2003.09.075

Simforoosh N; Basiri A; Pourrezagholi F; Einolahi B; Firouzan A; Moghaddam MM; Nourbala MH; Hajarizadeh B; Pourfarziani V; Lessanpezeshki M, 2003, 'Is preemptive renal transplantation preferred?', Transplantation Proceedings, vol. 35, pp. 2598 - 2601, http://dx.doi.org/10.1016/j.transproceed.2003.09.026

Alavian SM; Hajarizadeh B; Einollahi B, 2003, 'Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients', Transplantation Proceedings, vol. 35, pp. 2687 - 2688, http://dx.doi.org/10.1016/j.transproceed.2003.08.042

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, 'No evidence for higher risk of hepatocellular carcinoma occurrence or recurrence following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S12 - S12, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 - 23 April 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056600024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sheridan DA; Hajarizadeh B; Matthews G; Applegate TL; Douglas MW; Askew B; Neely D; Bassendine MF; Dore GJ; Lloyd AR, 2014, 'Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 929A - 929A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Grebely J; Dalgard O; Conway B; Foster G; Bruggmann P; Backmund M; Robaeys G; Swan T; Hajarizadeh B; Amin J, 2015, 'EFFICACY OF RESPONSE-GUIDED PEGYLATED INTERFERON AND RIBAVIRIN THERAPY FOR PEOPLE WHO INJECT DRUGS WITH HCV GENOTYPE 2/3 INFECTION: THE ACTIVATE STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, Vol. 62, pp. S657 - S657, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, 22 - 26 April 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362830900043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a